Metagenomi Therapeutics, Inc. Employee Count
The employee counts Metagenomi Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 119; Filing 2026-03-05; Lease expense per employee $112,386.55.
- 2024-12-31: Employees (as filed) 202; Filing 2025-03-17; Lease expense per employee $64,163.37.
- 2023-12-31: Employees (as filed) 236; Filing 2024-03-27; Lease expense per employee $52,614.41.
- Available history
- 2023-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 119 full-time | 2026-03-05 | $112,386.55 total lease cost |
| 2024-12-31 | 202 full-time | 2025-03-17 | $64,163.37 total lease cost |
| 2023-12-31 | 236 full-time | 2024-03-27 | $52,614.41 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |